Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Functional testing of a human PBX3 variant in zebrafish reveals a potential modifier role in congenital heart defects.

Farr GH 3rd, Imani K, Pouv D, Maves L.

Dis Model Mech. 2018 Oct 18;11(10). pii: dmm035972. doi: 10.1242/dmm.035972.

2.

BMP and FGF signaling interact to pattern mesoderm by controlling basic helix-loop-helix transcription factor activity.

Row RH, Pegg A, Kinney BA, Farr GH 3rd, Maves L, Lowell S, Wilson V, Martin BL.

Elife. 2018 Jun 7;7. pii: e31018. doi: 10.7554/eLife.31018.

3.

Lipid Nanoparticle Packaging Is an Effective and Nontoxic mRNA Delivery Platform in Embryonic Zebrafish.

Patton C, Farr GH 3rd, An D, Martini PGV, Maves L.

Zebrafish. 2018 Jun;15(3):217-227. doi: 10.1089/zeb.2017.1511. Epub 2018 Jan 25.

PMID:
29369745
4.

Pbx4 is Required for the Temporal Onset of Zebrafish Myocardial Differentiation.

Kao RM, Rurik JG, Farr GH 3rd, Dong XR, Majesky MW, Maves L.

J Dev Biol. 2015;3(4):93-111.

5.

Wnt signaling and tbx16 form a bistable switch to commit bipotential progenitors to mesoderm.

Bouldin CM, Manning AJ, Peng YH, Farr GH 3rd, Hung KL, Dong A, Kimelman D.

Development. 2015 Jul 15;142(14):2499-507. doi: 10.1242/dev.124024. Epub 2015 Jun 10.

6.

Conversion of MyoD to a neurogenic factor: binding site specificity determines lineage.

Fong AP, Yao Z, Zhong JW, Johnson NM, Farr GH 3rd, Maves L, Tapscott SJ.

Cell Rep. 2015 Mar 31;10(12):1937-46. doi: 10.1016/j.celrep.2015.02.055. Epub 2015 Mar 19.

7.

Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147.

Huang J, Nair SG, Mahoney MR, Nelson GD, Shields AF, Chan E, Goldberg RM, Gill S, Kahlenberg MS, Quesenberry JT, Thibodeau SN, Smyrk TC, Grothey A, Sinicrope FA, Webb TA, Farr GH Jr, Pockaj BA, Berenberg JL, Mooney M, Sargent DJ, Alberts SR; Alliance for Clinical Trials in Oncology.

Clin Colorectal Cancer. 2014 Jun;13(2):100-9. doi: 10.1016/j.clcc.2013.12.002. Epub 2013 Dec 28.

8.

Restricted expression of cdc25a in the tailbud is essential for formation of the zebrafish posterior body.

Bouldin CM, Snelson CD, Farr GH 3rd, Kimelman D.

Genes Dev. 2014 Feb 15;28(4):384-95. doi: 10.1101/gad.233577.113. Epub 2014 Jan 29.

9.

The HDAC Inhibitor TSA Ameliorates a Zebrafish Model of Duchenne Muscular Dystrophy.

Johnson NM, Farr GH 3rd, Maves L.

PLoS Curr. 2013 Sep 17;5. pii: ecurrents.md.8273cf41db10e2d15dd3ab827cb4b027. doi: 10.1371/currents.md.8273cf41db10e2d15dd3ab827cb4b027.

10.

Pbx and Prdm1a transcription factors differentially regulate subsets of the fast skeletal muscle program in zebrafish.

Yao Z, Farr GH 3rd, Tapscott SJ, Maves L.

Biol Open. 2013 Apr 8;2(6):546-55. doi: 10.1242/bio.20133921. Print 2013 Jun 15.

11.

Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial.

Alberts SR, Sargent DJ, Nair S, Mahoney MR, Mooney M, Thibodeau SN, Smyrk TC, Sinicrope FA, Chan E, Gill S, Kahlenberg MS, Shields AF, Quesenberry JT, Webb TA, Farr GH Jr, Pockaj BA, Grothey A, Goldberg RM.

JAMA. 2012 Apr 4;307(13):1383-93. doi: 10.1001/jama.2012.385.

12.

Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52.

Bolton JS, O'Connell MJ, Mahoney MR, Farr GH Jr, Fitch TR, Maples WJ, Nagorney DM, Rubin J, Fuloria J, Steen PD, Alberts SR.

Clin Colorectal Cancer. 2012 Mar;11(1):31-7. doi: 10.1016/j.clcc.2011.03.029. Epub 2011 May 13.

13.

Gemcitabine and docetaxel for hepatocellular carcinoma: a phase II North Central Cancer Treatment Group clinical trial.

Alberts SR, Reid JM, Morlan BW, Farr GH Jr, Camoriano JK, Johnson DB, Enger JR, Seay TE, Kim GP.

Am J Clin Oncol. 2012 Oct;35(5):418-23.

14.

Are the Mallory bodies and intracellular hyaline bodies in neoplastic and non-neoplastic hepatocytes related?

Denk H, Stumptner C, Fuchsbichler A, Müller T, Farr G, Müller W, Terracciano L, Zatloukal K.

J Pathol. 2006 Apr;208(5):653-61.

PMID:
16477590
15.

Eomesodermin is a localized maternal determinant required for endoderm induction in zebrafish.

Bjornson CR, Griffin KJ, Farr GH 3rd, Terashima A, Himeda C, Kikuchi Y, Kimelman D.

Dev Cell. 2005 Oct;9(4):523-33.

16.

Pilot studies of single and combination antiretroviral therapy in patients with primary biliary cirrhosis.

Mason AL, Farr GH, Xu L, Hubscher SG, Neuberger JM.

Am J Gastroenterol. 2004 Dec;99(12):2348-55.

PMID:
15571581
17.

Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer.

Schild SE, Bonner JA, Shanahan TG, Brooks BJ, Marks RS, Geyer SM, Hillman SL, Farr GH Jr, Tazelaar HD, Krook JE, Geoffroy FJ, Salim M, Arusell RM, Mailliard JA, Schaefer PL, Jett JR.

Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):943-51.

PMID:
15234027
18.

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial.

Nair S, Diehl AM, Wiseman M, Farr GH Jr, Perrillo RP.

Aliment Pharmacol Ther. 2004 Jul 1;20(1):23-8.

19.

Phase II study of oral etoposide and intravenous paclitaxel in extensive-stage small cell lung cancer.

Perez EA, Geoffroy FJ, Hillman S, Johnson EA, Farr GH Jr, Tazelarr HD, Hatfield AK, Krook JE, Maillard JA, Levitt R, Marks RS.

Lung Cancer. 2004 Jun;44(3):347-53.

PMID:
15140548
20.

GBP binds kinesin light chain and translocates during cortical rotation in Xenopus eggs.

Weaver C, Farr GH 3rd, Pan W, Rowning BA, Wang J, Mao J, Wu D, Li L, Larabell CA, Kimelman D.

Development. 2003 Nov;130(22):5425-36. Epub 2003 Sep 24.

21.

Liver transplantation for hepatocellular carcinoma: the ochsner experience.

Loss GE Jr, Nair S, Blazek JL, Farr GH Jr, Eason JD.

Ochsner J. 2002 Fall;4(4):215-20.

22.

Prevalence and Prognostic Significance of Neuroendocrine Differentiation in Colorectal Carcinomas.

Lloyd RV, Schroeder G, Bauman MD, Krook JE, Jin L, Goldberg RM, Farr GH Jr.

Endocr Pathol. 1998 Spring;9(1):35-42.

PMID:
12114660
23.

A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of ductal carcinoma in situ.

King TA, Farr GH Jr, Cederbom GJ, Smetherman DH, Bolton JS, Stolier AJ, Fuhrman GM.

Am Surg. 2001 Sep;67(9):907-12.

PMID:
11565774
24.

A randomized trial of interferon-alpha in cervical dysplasia.

Gostout BS, Hartmann LC, Suman VJ, Fay NE, Jefferies JA, Morton RF, Gaffey TA, Farr GH Jr, Tschetter LK, Abu-Ghazaleh S, Gallenberg MM, Hatfield AK.

Int J Gynaecol Obstet. 2001 Aug;74(2):207-10. No abstract available.

PMID:
11502303
25.

Biopsy technique has no impact on local recurrence after breast-conserving therapy.

King TA, Hayes DH, Cederbom GJ, Champaign JL, Smetherman DH, Farr GH, Bolton JS, Fuhrman GM.

Breast J. 2001 Jan-Feb;7(1):19-24.

PMID:
11348411
26.

Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway.

Mao J, Wang J, Liu B, Pan W, Farr GH 3rd, Flynn C, Yuan H, Takada S, Kimelman D, Li L, Wu D.

Mol Cell. 2001 Apr;7(4):801-9.

27.

Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification.

Farr GH 3rd, Ferkey DM, Yost C, Pierce SB, Weaver C, Kimelman D.

J Cell Biol. 2000 Feb 21;148(4):691-702.

28.

Benign diagnosis by image-guided core-needle breast biopsy.

Duncan JL 3rd, Cederbom GJ, Champaign JL, Smetherman DH, King TA, Farr GH, Waring AN, Bolton JS, Fuhrman GM.

Am Surg. 2000 Jan;66(1):5-9; discussion 9-10.

PMID:
10651339
29.

Lessons learned from the initial 100 patient experience with sentinel lymph node mapping in the evaluation of breast cancer.

Fuhrman GM, Burch EG, Farr GH, King TA, Farkas E, Bolton JS.

Ochsner J. 2000 Jan;2(1):19-23.

30.

Recurrent juvenile-onset laryngotracheal papillomatosis with transformation to squamous cell carcinoma of the lung.

Yantsos VA, Farr GH Jr, McFadden PM, Emory WB.

South Med J. 1999 Oct;92(10):1013-6.

PMID:
10548177
31.

Radial scar of the breast: radiologic-pathologic correlation in 22 cases.

Alleva DQ, Smetherman DH, Farr GH Jr, Cederbom GJ.

Radiographics. 1999 Oct;19 Spec No:S27-35; discussion S36-7.

PMID:
10517441
32.

Discontinuous appendiceal involvement in ulcerative colitis: pathology and clinical correlation.

Perry WB, Opelka FG, Smith D, Hicks TC, Timmcke AE, Gathright JB Jr, Farr GH Jr, Beck DE.

J Gastrointest Surg. 1999 Mar-Apr;3(2):141-4.

PMID:
10457336
33.

Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers.

Halling KC, French AJ, McDonnell SK, Burgart LJ, Schaid DJ, Peterson BJ, Moon-Tasson L, Mahoney MR, Sargent DJ, O'Connell MJ, Witzig TE, Farr GH Jr, Goldberg RM, Thibodeau SN.

J Natl Cancer Inst. 1999 Aug 4;91(15):1295-303.

PMID:
10433618
34.

Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1.

Li L, Yuan H, Weaver CD, Mao J, Farr GH 3rd, Sussman DJ, Jonkers J, Kimelman D, Wu D.

EMBO J. 1999 Aug 2;18(15):4233-40.

35.

A core breast biopsy diagnosis of invasive carcinoma allows for definitive surgical treatment planning.

King TA, Cederbom GJ, Champaign JL, Smetherman DH, Bolton JS, Farr GH, McKinnon WM, Kuske RR, Fuhrman GM.

Am J Surg. 1998 Dec;176(6):497-501.

PMID:
9926778
36.

GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis.

Yost C, Farr GH 3rd, Pierce SB, Ferkey DM, Chen MM, Kimelman D.

Cell. 1998 Jun 12;93(6):1031-41.

37.

Image-guided core-needle breast biopsy is an accurate technique to evaluate patients with nonpalpable imaging abnormalities.

Fuhrman GM, Cederbom GJ, Bolton JS, King TA, Duncan JL, Champaign JL, Smetherman DH, Farr GH, Kuske RR, McKinnon WM.

Ann Surg. 1998 Jun;227(6):932-9.

38.

Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1.

Thibodeau SN, French AJ, Cunningham JM, Tester D, Burgart LJ, Roche PC, McDonnell SK, Schaid DJ, Vockley CW, Michels VV, Farr GH Jr, O'Connell MJ.

Cancer Res. 1998 Apr 15;58(8):1713-8.

39.

Appropriate management of atypical ductal hyperplasia diagnosed by stereotactic core needle breast biopsy.

Gadzala DE, Cederbom GJ, Bolton JS, McKinnon WM, Farr GH Jr, Champaign J, Ordoyne K, Chung K, Fuhrman GM.

Ann Surg Oncol. 1997 Jun;4(4):283-6.

PMID:
9181225
40.

Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma: its importance in long-term survival.

Zanetta G, Keeney GL, Cha SS, Farr GH Jr, Katzmann JA, Wieand HS, Edmonson JH, Podratz KC.

Am J Obstet Gynecol. 1996 Nov;175(5):1217-25.

PMID:
8942491
42.

Chronic hepatitis and hepatic failure in a 14-year-old girl.

Ludwig J, Farr GH, Freese DK, Sternlieb I.

Hepatology. 1995 Dec;22(6):1874-9. No abstract available.

PMID:
7490000
43.

Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocol.

Hartmann LC, Ingle JN, Wold LE, Farr GH Jr, Grill JP, Su JQ, Maihle NJ, Krook JE, Witzig TE, Roche PC.

Cancer. 1994 Dec 1;74(11):2956-63.

PMID:
7954259
44.

Ischemia-reperfusion injury of the spinal cord: protective effect of the hydroxyl radical scavenger dimethylthiourea.

Wisselink W, Money SR, Crockett DE, Nguyen JH, Becker MO, Farr GH, Hollier LH.

J Vasc Surg. 1994 Sep;20(3):444-91; discussion 449-50.

PMID:
8084038
45.

Nodular regenerative hyperplasia: a controversial indication for orthotopic liver transplantation.

Elariny HA, Mizrahi SS, Hayes DH, Boudreaux JP, Hussey JL, Farr GH Jr.

Transpl Int. 1994 Jul;7(4):309-13. Review.

PMID:
7916934
46.

Is breast preservation possible in women with large, locally advanced breast cancers?

Kuske RR, Farr GH, Harris K, Bolton JS, Sardi A, McKinnon WH, Kardinal CG, Cole J, Pickett TK, Graham ML, et al.

J La State Med Soc. 1993 Apr;145(4):165-7.

PMID:
8486989
47.

The value of flow cytometric analysis in multicentric glomus tumors of the head and neck.

Sauter ER, Hollier LH, Farr GH Jr.

Cancer. 1992 Mar 15;69(6):1452-6.

PMID:
1311625
48.

Wilms' tumor with metastasis to the left testis.

Sauter ER, Schorin MA, Farr GH Jr, Falterman KW, Arensman RM.

Am Surg. 1990 Apr;56(4):260-2.

PMID:
2163592
49.

Improved survival after pulmonary resection of metastatic colorectal carcinoma.

Sauter ER, Bolton JS, Willis GW, Farr GH, Sardi A.

J Surg Oncol. 1990 Mar;43(3):135-8.

PMID:
2314100
50.

Is limb-sparing surgery applicable to neurogenic sarcomas of the extremities?

Bolton JS, Vauthey JN, Farr GH Jr, Sauter EI, Bowen JC 3rd, Kline DG.

Arch Surg. 1989 Jan;124(1):118-21.

PMID:
2910239

Supplemental Content

Loading ...
Support Center